{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:03:40Z","timestamp":1792803820483,"version":"4.5.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"19","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101076961"],"award-info":[{"award-number":["101076961"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024571","name":"KU | Novo Nordisk Foundation Center for Protein Research, University of Copenhagen","doi-asserted-by":"publisher","award":["NNF18SA0035142 & NNF22OC0079182"],"award-info":[{"award-number":["NNF18SA0035142 & NNF22OC0079182"]}],"id":[{"id":"10.13039\/501100024571","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Independent Research Fund Denmark","award":["10.46540\/2064-00032B"],"award-info":[{"award-number":["10.46540\/2064-00032B"]}],"id":[{"id":"https:\/\/ror.org\/05svhj534","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Dr.phil Ragna Rask-Nielsens Grundforskningsfond"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The study of Alzheimer\u2019s disease (AD)-associated mutations has implicated dysregulation of amyloid precursor protein (APP) proteolysis in the disease. Brain recordings have revealed synaptic hyperexcitation during asymptomatic and early stages of AD, reverting to overinhibition as dementia progresses. Here, we show that endogenous APP and its proteolytic C-terminal fragments (APP-CTFs), the precursors of amyloid-\u03b2 (A\u03b2), are enriched at excitatory synapses. Pharmacological modulation of endogenous APP metabolite levels suggests a role for APP-CTFs, in particular APP-CTF\u03b2, in regulating glutamatergic synaptic transmission. Presynaptic accumulation of APP-CTF\u03b2 promotes its oligomerization, increases synaptic vesicle docking, and causes vesicle release defects, accompanied by enhanced neuronal network activity. Examination of post-mortem AD patient brains yields consistent results, namely, elevated APP-CTF\u03b2 levels at synaptic compartments and enlarged excitatory presynaptic boutons. Strikingly, acute application of A\u03b2 preparations enriched in monomeric species counteracts APP-CTF\u03b2-induced hyperexcitability. Our findings indicate a role for presynaptic APP-CTF\u03b2 in modulating excitatory synaptic function and network activity, suggesting that amyloidogenic APP processing intermediates may contribute to early synaptic alterations in Alzheimer\u2019s disease.<\/jats:p>","DOI":"10.1038\/s44318-026-00899-6","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:34:30Z","timestamp":1788276870000},"page":"6914-6945","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Presynaptic accumulation of APP-CTF\u03b2 may contribute to synaptic dysfunction in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7173-4122","authenticated-orcid":false,"given":"Akshay","family":"Kapadia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3768-6494","authenticated-orcid":false,"given":"Fabian","family":"Schuhmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6542-2608","authenticated-orcid":false,"given":"Ezgi","family":"Daskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabell","family":"Lindahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjado H J","family":"Morrema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2528-4428","authenticated-orcid":false,"given":"Annemieke J M","family":"Rozemuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4922-3286","authenticated-orcid":false,"given":"Baayla D C","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weria","family":"Pezeshkian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4416-7307","authenticated-orcid":false,"given":"Anne-Sophie","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"899_CR1","doi-asserted-by":"crossref","unstructured":"Anastacio HTD, Matosin N, Ooi L (2022) Neuronal hyperexcitability in Alzheimer\u2019s disease: what are the drivers behind this aberrant phenotype? Transl Psychiatry 12:257","DOI":"10.1038\/s41398-022-02024-7"},{"key":"899_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1749-6632.2000.tb06917.x","volume":"920","author":"W Annaert","year":"2000","unstructured":"Annaert W, Cupers P, Saftig P, De Strooper B (2000) Presenilin function in APP processing. Ann N Y Acad Sci 920:158\u2013164","journal-title":"Ann N Y Acad Sci"},{"key":"899_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-026-02928-7","volume":"24","author":"C Badot","year":"2026","unstructured":"Badot C, Bini A, Duplan E, Checler F, Lauritzen I (2026) Functional relationships linking C99\/APP-\u03b2CTF dimerization, proteostasis disruption, and organelle dysfunction. Cell Commun Signal 24:382","journal-title":"Cell Commun Signal"},{"key":"899_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06813-x","volume":"9","author":"G Barthet","year":"2018","unstructured":"Barthet G, Jord\u00e0-Siquier T, Rumi-Masante J, Bernadou F, M\u00fcller U, Mulle C (2018) Presenilin-mediated cleavage of APP regulates synaptotagmin-7 and presynaptic plasticity. Nat Commun 9:4780","journal-title":"Nat Commun"},{"key":"899_CR6","unstructured":"B\u00e9cot A (2019) APP-CTFs in Alzheimer's Disease: Role of Lysosomal-Autophagic Degradation and Exosomal Secretion, TEL - Th\u00e8ses en ligne. France. Retrieved from https:\/\/coilink.org\/20.500.12592\/1575618 on 13 Aug 2026"},{"key":"899_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ajpath.2015.09.018","volume":"186","author":"T Bilousova","year":"2016","unstructured":"Bilousova T, Miller CA, Poon WW, Vinters HV, Corrada M, Kawas C, Hayden EY, Teplow DB, Glabe C, Albay 3rdR et al (2016) Synaptic amyloid-\u03b2 oligomers precede p-tau and differentiate high pathology control cases. Am J Pathol 186:185\u2013198","journal-title":"Am J Pathol"},{"key":"899_CR8","doi-asserted-by":"publisher","first-page":"108966","DOI":"10.1016\/j.abb.2021.108966","volume":"709","author":"B Binotti","year":"2021","unstructured":"Binotti B, Jahn R, P\u00e9rez-Lara \u00c1 (2021) An overview of the synaptic vesicle lipid composition. Arch Biochem Biophys 709:108966","journal-title":"Arch Biochem Biophys"},{"key":"899_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-020-02198-8","volume":"140","author":"BDC Boon","year":"2020","unstructured":"Boon BDC, Bulk M, Jonker AJ, Morrema THJ, van den Berg E, Popovic M, Walter J, Kumar S, van der Lee SJ, Holstege H et al (2020) The coarse-grained plaque: a divergent A\u03b2 plaque-type in early-onset Alzheimer\u2019s disease. Acta Neuropathol 140:811\u2013830","journal-title":"Acta Neuropathol"},{"key":"899_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1180-y","volume":"15","author":"BDC Boon","year":"2018","unstructured":"Boon BDC, Hoozemans JJM, Lopuha\u00e4 B, Eigenhuis KN, Scheltens P, Kamphorst W, Rozemuller AJM, Bouwman FH (2018) Neuroinflammation is increased in the parietal cortex of atypical Alzheimer\u2019s disease. J Neuroinflammation 15:170","journal-title":"J Neuroinflammation"},{"key":"899_CR11","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.devcel.2024.03.030","volume":"59","author":"M Bretou","year":"2024","unstructured":"Bretou M, Sannerud R, Escamilla-Ayala A, Leroy T, Vrancx C, Van Acker ZP, Perdok A, Vermeire W, Vorsters I, Van Keymolen S et al (2024) Accumulation of APP C-terminal fragments causes endolysosomal dysfunction through the dysregulation of late endosome to lysosome-ER contact sites. Dev Cell 59:1571\u20131592.e9","journal-title":"Dev Cell"},{"key":"899_CR143","doi-asserted-by":"crossref","unstructured":"Brockhaus M, Gr\u00fcnberg J, R\u00f6hrig S, Loetscher H, Wittenburg N, Baumeister R, Jacobsen H, Haass C (1998) Caspase-mediated cleavage is not required for the activity of presenilins in amyloidogenesis and NOTCH signaling. Neuroreport 9:1481\u20131486","DOI":"10.1097\/00001756-199805110-00043"},{"key":"899_CR12","doi-asserted-by":"publisher","first-page":"jcs255752","DOI":"10.1242\/jcs.255752","volume":"134","author":"T Burrinha","year":"2021","unstructured":"Burrinha T, Martinsson I, Gomes R, Terrasso AP, Gouras GK, Almeida CG (2021) Upregulation of APP endocytosis by neuronal aging drives amyloid-dependent synapse loss. J Cell Sci 134:jcs255752","journal-title":"J Cell Sci"},{"key":"899_CR13","doi-asserted-by":"publisher","unstructured":"Campos-Pe\u00f1a V, Meraz-R\u00edos M (2014) Alzheimer Disease: The Role of A\u03b2 in the Glutamatergic System. Neurochemistry. InTech; https:\/\/doi.org\/10.5772\/57367","DOI":"10.5772\/57367"},{"key":"899_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12035-012-8251-3","volume":"45","author":"V Cavallucci","year":"2012","unstructured":"Cavallucci V, D\u2019Amelio M, Cecconi F (2012) A\u03b2 toxicity in Alzheimer\u2019s disease. Mol Neurobiol 45:366\u2013378","journal-title":"Mol Neurobiol"},{"key":"899_CR15","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s12035-019-01835-y","volume":"57","author":"C Cefaliello","year":"2020","unstructured":"Cefaliello C, Penna E, Barbato C, Di Ruberto G, Mollica MP, Trinchese G, Cigliano L, Borsello T, Chun JT, Giuditta A et al (2020) Deregulated local protein synthesis in the brain synaptosomes of a mouse model for Alzheimer\u2019s disease. Mol Neurobiol 57:1529\u20131541","journal-title":"Mol Neurobiol"},{"key":"899_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2174\/156720508784533321","volume":"5","author":"W Cerpa","year":"2008","unstructured":"Cerpa W, Dinamarca MC, Inestrosa NC (2008) Structure-function implications in Alzheimer\u2019s disease: effect of Abeta oligomers at central synapses. Curr Alzheimer Res 5:233\u2013243","journal-title":"Curr Alzheimer Res"},{"key":"899_CR17","first-page":"201","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, Chen J-S, Li S, Zhang F, Deng J, Zeng L-H, Tan J (2024) Amyloid precursor protein: a regulatory hub in Alzheimer\u2019s disease. Aging Dis 15:201\u2013225","journal-title":"Aging Dis"},{"key":"899_CR18","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/S0024-3205(99)80009-5","volume":"63","author":"J Daly 4th","year":"1998","unstructured":"Daly J 4th, Lahiri DK, Justus DE, Kotwal GJ (1998) Detection of the membrane-retained carboxy-terminal tail containing polypeptides of the amyloid precursor protein in tissue from Alzheimer\u2019s disease brain. Life Sci 63:2121\u20132131","journal-title":"Life Sci"},{"key":"899_CR19","doi-asserted-by":"publisher","first-page":"6394","DOI":"10.1038\/s41380-021-01166-2","volume":"26","author":"B Das","year":"2021","unstructured":"Das B, Singh N, Yao AY, Zhou J, He W, Hu X, Yan R (2021) BACE1 controls synaptic function through modulating release of synaptic vesicles. Mol Psychiatry 26:6394\u20136410","journal-title":"Mol Psychiatry"},{"key":"899_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-017-0093-5","volume":"6","author":"B Das","year":"2017","unstructured":"Das B, Yan R (2017) Role of BACE1 in Alzheimer\u2019s synaptic function. Transl Neurodegener 6:23","journal-title":"Transl Neurodegener"},{"key":"899_CR21","doi-asserted-by":"publisher","first-page":"e108576","DOI":"10.1371\/journal.pone.0108576","volume":"9","author":"D Del Prete","year":"2014","unstructured":"Del Prete D, Lombino F, Liu X, D\u2019Adamio L (2014) APP is cleaved by Bace1 in pre-synaptic vesicles and establishes a pre-synaptic interactome, via its intracellular domain, with molecular complexes that regulate pre-synaptic vesicles functions. PLoS ONE 9:e108576","journal-title":"PLoS ONE"},{"key":"899_CR22","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3389\/fphys.2012.00464","volume":"3","author":"MC Dinamarca","year":"2012","unstructured":"Dinamarca MC, R\u00edos JA, Inestrosa NC (2012) Postsynaptic receptors for amyloid-\u03b2 oligomers as mediators of neuronal damage in Alzheimer\u2019s disease. Front Physiol 3:464","journal-title":"Front Physiol"},{"key":"899_CR23","doi-asserted-by":"publisher","first-page":"8812","DOI":"10.1523\/JNEUROSCI.1318-23.2023","volume":"43","author":"EA Eckman","year":"2023","unstructured":"Eckman EA, Clausen DM, Sol\u00e9-Dom\u0117nech S, Lee CW, Sinobas-Pereira C, Domalewski RJ, Nichols MR, Pacheco-Quinto J (2023) Nascent A\u03b242 fibrillization in synaptic endosomes precedes plaque formation in a mouse model of Alzheimer\u2019s-like \u03b2-amyloidosis. J Neurosci 43:8812\u20138824","journal-title":"J Neurosci"},{"key":"899_CR24","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1016\/j.neuron.2023.07.005","volume":"111","author":"S Essayan-Perez","year":"2023","unstructured":"Essayan-Perez S, S\u00fcdhof TC (2023) Neuronal \u03b3-secretase regulates lipid metabolism, linking cholesterol to synaptic dysfunction in Alzheimer\u2019s disease. Neuron 111:3176\u20133194.e7","journal-title":"Neuron"},{"key":"899_CR25","doi-asserted-by":"publisher","first-page":"e12879","DOI":"10.1111\/nan.12879","volume":"49","author":"P Ferrer-Ravent\u00f3s","year":"2023","unstructured":"Ferrer-Ravent\u00f3s P, Puertollano-Mart\u00edn D, Querol-Vilaseca M, S\u00e1nchez-Aced \u00c9, Valle-Tamayo N, Cervantes-Gonzalez A, Nu\u00f1ez-Llaves R, Pegueroles J, Dols-Icardo O, Iulita MF et al (2023) Amyloid precursor protein \u03b2CTF accumulates in synapses in sporadic and genetic forms of Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 49:e12879","journal-title":"Neuropathol Appl Neurobiol"},{"key":"899_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06519-0","volume":"9","author":"EF Fornasiero","year":"2018","unstructured":"Fornasiero EF, Mandad S, Wildhagen H, Alevra M, Rammner B, Keihani S, Opazo F, Urban I, Ischebeck T, Sakib MS et al (2018) Precisely measured protein lifetimes in the mouse brain reveal differences across tissues and subcellular fractions. Nat Commun 9:4230","journal-title":"Nat Commun"},{"key":"899_CR27","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0002-9440(10)63159-8","volume":"164","author":"H Fukumoto","year":"2004","unstructured":"Fukumoto H, Rosene DL, Moss MB, Raju S, Hyman BT, Irizarry MC (2004) Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am J Pathol 164:719\u2013725","journal-title":"Am J Pathol"},{"key":"899_CR28","doi-asserted-by":"crossref","unstructured":"Gaetani L, Bellomo G, Chiasserini D, De Rocker C, Goossens J, Paoletti FP, Vanmechelen E, Parnetti L (2025) Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer\u2019s disease and Parkinson\u2019s disease. Alzheimer's Res Ther 17:115","DOI":"10.1186\/s13195-025-01762-2"},{"key":"899_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02841-7","volume":"7","author":"M-S Garc\u00eda-Ayll\u00f3n","year":"2017","unstructured":"Garc\u00eda-Ayll\u00f3n M-S, Lopez-Font I, Boix CP, Fortea J, S\u00e1nchez-Valle R, Lle\u00f3 A, Molinuevo J-L, Zetterberg H, Blennow K, S\u00e1ez-Valero J (2017) C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease. Sci Rep 7:2477","journal-title":"Sci Rep"},{"key":"899_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13024-015-0028-5","volume":"10","author":"V Gautam","year":"2015","unstructured":"Gautam V, D\u2019Avanzo C, Berezovska O, Tanzi RE, Kovacs DM (2015) Synaptotagmins interact with APP and promote A\u03b2 generation. Mol Neurodegener 10:31","journal-title":"Mol Neurodegener"},{"key":"899_CR31","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.neuron.2023.11.014","volume":"112","author":"J Giorgio","year":"2024","unstructured":"Giorgio J, Adams JN, Maass A, Jagust WJ, Breakspear M (2024) Amyloid induced hyperexcitability in default mode network drives medial temporal hyperactivity and early tau accumulation. Neuron 112:676\u2013686.e4","journal-title":"Neuron"},{"key":"899_CR32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2113929118","volume":"118","author":"C Glock","year":"2021","unstructured":"Glock C, Biever A, Tushev G, Nassim-Assir B, Kao A, Bartnik I, Tom Dieck S, Schuman EM (2021) The translatome of neuronal cell bodies, dendrites, and axons. Proc Natl Acad Sci USA 118:e2113929118","journal-title":"Proc Natl Acad Sci USA"},{"key":"899_CR33","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.90633","volume":"13","author":"A Granzotto","year":"2024","unstructured":"Granzotto A, Vissel B, Sensi SL (2024) Lost in translation: Inconvenient truths on the utility of mouse models in Alzheimer\u2019s disease research. eLife 13:e90633","journal-title":"eLife"},{"key":"899_CR34","doi-asserted-by":"publisher","first-page":"e18754","DOI":"10.1371\/journal.pone.0018754","volume":"6","author":"TW Groemer","year":"2011","unstructured":"Groemer TW, Thiel CS, Holt M, Riedel D, Hua Y, H\u00fcve J, Wilhelm BG, Klingauf J (2011) Amyloid precursor protein is trafficked and secreted via synaptic vesicles. PLoS ONE 6:e18754","journal-title":"PLoS ONE"},{"key":"899_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fnmol.2017.00087","volume":"10","author":"S Gu\u00e9nette","year":"2017","unstructured":"Gu\u00e9nette S, Strecker P, Kins S (2017) APP protein family signaling at the synapse: Insights from intracellular APP-binding proteins. Front Mol Neurosci 10:87","journal-title":"Front Mol Neurosci"},{"key":"899_CR36","doi-asserted-by":"publisher","first-page":"a006270","DOI":"10.1101\/cshperspect.a006270","volume":"2","author":"C Haass","year":"2012","unstructured":"Haass C, Kaether C, Thinakaran G, Sisodia S (2012) Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med 2:a006270","journal-title":"Cold Spring Harb Perspect Med"},{"key":"899_CR37","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau3644","volume":"364","author":"A-S Hafner","year":"2019","unstructured":"Hafner A-S, Donlin-Asp PG, Leitch B, Herzog E, Schuman EM (2019) Local protein synthesis is a ubiquitous feature of neuronal pre- and postsynaptic compartments. Science 364:eaau3644","journal-title":"Science"},{"key":"899_CR38","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T et al (2021) The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry 26:5481\u20135503","journal-title":"Mol Psychiatry"},{"key":"899_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/362014a0","volume":"362","author":"MR Hanley","year":"1993","unstructured":"Hanley MR, Selkoe DJ (1993) Alzheimer\u2019s disease. Amyloid precursor on the G(o). Nature 362:14\u201315","journal-title":"Nature"},{"key":"899_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13024-016-0110-7","volume":"11","author":"CS Harwell","year":"2016","unstructured":"Harwell CS, Coleman MP (2016) Synaptophysin depletion and intraneuronal A\u03b2 in organotypic hippocampal slice cultures from huAPP transgenic mice. Mol Neurodegener 11:44","journal-title":"Mol Neurodegener"},{"key":"899_CR41","doi-asserted-by":"publisher","first-page":"600084","DOI":"10.3389\/fnmol.2020.600084","volume":"13","author":"A Hector","year":"2020","unstructured":"Hector A, Brouillette J (2020) Hyperactivity induced by soluble amyloid-\u03b2 oligomers in the early stages of Alzheimer\u2019s disease. Front Mol Neurosci 13:600084","journal-title":"Front Mol Neurosci"},{"key":"899_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang J, Rauscher S, Nawrocki G, Ran T, Feig M, de Groot BL, Grubm\u00fcller H, MacKerell AD Jr (2017) CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods 14:71\u201373","journal-title":"Nat Methods"},{"key":"899_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12952-017-0066-3","volume":"16","author":"S Hunter","year":"2017","unstructured":"Hunter S, Brayne C (2017) Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research? J Negat Results Biomed 16:1","journal-title":"J Negat Results Biomed"},{"key":"899_CR44","first-page":"50557","volume":"31","author":"S Iwabuchi","year":"2014","unstructured":"Iwabuchi S, Kakazu Y, Koh J-Y, Goodman KM, Harata NC (2014) Examination of synaptic vesicle recycling using FM dyes during evoked, spontaneous, and miniature synaptic activities. J Vis Exp 31:50557","journal-title":"J Vis Exp"},{"key":"899_CR45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1517\/14712590902828285","volume":"9","author":"GA Jicha","year":"2009","unstructured":"Jicha GA (2009) Is passive immunization for Alzheimer\u2019s disease \u2018alive and well\u2019 or \u2018dead and buried\u2019? Expert Opin Biol Ther 9:481\u2013491","journal-title":"Expert Opin Biol Ther"},{"key":"899_CR46","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jconrel.2024.09.012","volume":"375","author":"Y Jin","year":"2024","unstructured":"Jin Y, Du Q, Song M, Kang R, Zhou J, Zhang H, Ding Y (2024) Amyloid-\u03b2-targeting immunotherapies for Alzheimer\u2019s disease. J Control Release 375:346\u2013365","journal-title":"J Control Release"},{"key":"899_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T J\u00f3nsson","year":"2012","unstructured":"J\u00f3nsson T, Atwal J, Steinberg S, Snaedal J, Jonsson P, Bjornsson S, Stef\u00e1nsson H, Sulem P, Gudbjartsson D, Maloney JA et al (2012) A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 488:96\u201399","journal-title":"Nature"},{"key":"899_CR48","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/alz.12546","volume":"18","author":"T Jord\u00e0-Siquier","year":"2022","unstructured":"Jord\u00e0-Siquier T, Petrel M, Kouskoff V, Smailovic U, Cordeli\u00e8res F, Frykman S, M\u00fcller U, Mulle C, Barthet G (2022) APP accumulates with presynaptic proteins around amyloid plaques: a role for presynaptic mechanisms in Alzheimer\u2019s disease? Alzheimers Dement 18:2099\u20132116","journal-title":"Alzheimers Dement"},{"key":"899_CR49","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s12640-020-00232-x","volume":"38","author":"MT Kabir","year":"2020","unstructured":"Kabir MT, Uddin MS, Setu JR, Ashraf GM, Bin-Jumah MN, Abdel-Daim MM (2020) Exploring the role of PSEN mutations in the pathogenesis of Alzheimer\u2019s disease. Neurotox Res 38:833\u2013849","journal-title":"Neurotox Res"},{"key":"899_CR50","doi-asserted-by":"publisher","first-page":"ENEURO.0418","DOI":"10.1523\/ENEURO.0418-20.2020","volume":"8","author":"S Kazim","year":"2021","unstructured":"Kazim S, Seo JH, Bianchi R, Larson CS, Sharma A, Wong R, Gorbachev K, Pereira AC (2021) Neuronal network excitability in Alzheimer\u2019s disease: the puzzle of similar versus divergent roles of amyloid \u03b2 and tau. eNeuro 8:ENEURO.0418\u201320.2020","journal-title":"eNeuro"},{"key":"899_CR51","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","volume":"140","author":"SA Kent","year":"2020","unstructured":"Kent SA, Spires-Jones TL, Durrant CS (2020) The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics. Acta Neuropathol 140:417\u2013447","journal-title":"Acta Neuropathol"},{"key":"899_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jalz.2005.11.003","volume":"2","author":"W Klein","year":"2006","unstructured":"Klein W (2006) Synaptic targeting by A\u03b2 oligomers (ADDLS) as a basis for memory loss in early Alzheimer\u2019s disease. Alzheimers Dement 2:43\u201355","journal-title":"Alzheimers Dement"},{"key":"899_CR53","doi-asserted-by":"crossref","unstructured":"Klein W, De Felice F, Lacor PN, Lambert MP, Zhao W-Q (2008) Why Alzheimer\u2019s is a disease of memory: synaptic targeting by pathogenic A\u03b2 oligomers (ADDLs). In Selkoe DJ, Welker E, Christen Y (eds.). Synaptic plasticity and the mechanism of Alzheimer\u2019s disease. Springer Berlin Heidelberg, pp 113\u2013134","DOI":"10.1007\/978-3-540-76330-7_9"},{"key":"899_CR54","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.nbd.2016.05.012","volume":"93","author":"A Kobro-Flatmoen","year":"2016","unstructured":"Kobro-Flatmoen A, Nagelhus A, Witter MP (2016) Reelin-immunoreactive neurons in entorhinal cortex layer II selectively express intracellular amyloid in early Alzheimer\u2019s disease. Neurobiol Dis 93:172\u2013183","journal-title":"Neurobiol Dis"},{"key":"899_CR55","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1021\/pr300123g","volume":"11","author":"BM Kohli","year":"2012","unstructured":"Kohli BM, Pflieger D, Mueller LN, Carbonetti G, Aebersold R, Nitsch RM, Konietzko U (2012) Interactome of the amyloid precursor protein APP in brain reveals a protein network involved in synaptic vesicle turnover and a close association with Synaptotagmin-1. J Proteome Res 11:4075\u20134090","journal-title":"J Proteome Res"},{"key":"899_CR56","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.jalz.2009.03.002","volume":"5","author":"T Kokjohn","year":"2009","unstructured":"Kokjohn T, Roher A (2009) Amyloid precursor protein transgenic mouse models and Alzheimer\u2019s disease: understanding the paradigms, limitations, and contributions. Alzheimers Dement 5:340\u2013347","journal-title":"Alzheimers Dement"},{"key":"899_CR57","doi-asserted-by":"crossref","unstructured":"Kroon PC, Gr\u00fcnewald F, Barnoud J, van Tilburg M, Brasnett C, Souza PC, Wassenaar TA, Marrink SJ (2025) Martinize2 and Vermouth provide a unified framework for molecular topology generation. Elife 12:RP90627","DOI":"10.7554\/eLife.90627"},{"key":"899_CR58","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40035-019-0176-6","volume":"8","author":"I Lauritzen","year":"2019","unstructured":"Lauritzen I, B\u00e9cot A, Bourgeois A, Pardossi-Piquard R, Biferi M-G, Barkats M, Checler F (2019a) Targeting \u03b3-secretase triggers the selective enrichment of oligomeric APP-CTFs in brain extracellular vesicles from Alzheimer cell and mouse models. Transl Neurodegener 8:35","journal-title":"Transl Neurodegener"},{"key":"899_CR59","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2174\/1567205016666190325092841","volume":"16","author":"I Lauritzen","year":"2019","unstructured":"Lauritzen I, Pardossi-Piquard R, Bourgeois A, B\u00e9cot A, Checler F (2019b) Does intraneuronal accumulation of carboxyl-terminal fragments of the amyloid precursor protein trigger early neurotoxicity in Alzheimer\u2019s disease? Curr Alzheimer Res 16:453\u2013457","journal-title":"Curr Alzheimer Res"},{"key":"899_CR60","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00401-016-1577-6","volume":"132","author":"I Lauritzen","year":"2016","unstructured":"Lauritzen I, Pardossi-Piquard R, Bourgeois A, Pagnotta S, Biferi M-G, Barkats M, Lacor P, Klein W, Bauer C, Checler F (2016) Intraneuronal aggregation of the \u03b2-CTF fragment of APP (C99) induces A\u03b2-independent lysosomal-autophagic pathology. Acta Neuropathol 132:257\u2013276","journal-title":"Acta Neuropathol"},{"key":"899_CR61","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neuron.2016.02.033","volume":"90","author":"E Lauwers","year":"2016","unstructured":"Lauwers E, Goodchild R, Verstreken P (2016) Membrane lipids in presynaptic function and disease. Neuron 90:11\u201325","journal-title":"Neuron"},{"key":"899_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-021-00796-3","volume":"8","author":"S-E Lee","year":"2022","unstructured":"Lee S-E, Kwon D, Shin N, Kong D, Kim NG, Kim H-Y, Kim M-J, Choi SW, Kang K-S (2022) Accumulation of APP-CTF induces mitophagy dysfunction in the iNSCs model of Alzheimer\u2019s disease. Cell Death Discov 8:1","journal-title":"Cell Death Discov"},{"key":"899_CR63","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.neuron.2020.08.011","volume":"108","author":"SH Lee","year":"2020","unstructured":"Lee SH, Kang J, Ho A, Watanabe H, Bolshakov VY, Shen J (2020) APP family regulates neuronal excitability and synaptic plasticity but not neuronal survival. Neuron 108:676\u2013690.e8","journal-title":"Neuron"},{"key":"899_CR64","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/jnc.13713","volume":"138","author":"K Lepeta","year":"2016","unstructured":"Lepeta K, Lourenco MV, Schweitzer BC, Martino Adami PV, Banerjee P, Catuara-Solarz S, de La Fuente Revenga M, Guillem AM, Haidar M, Ijomone OM et al (2016) Synaptopathies: synaptic dysfunction in neurological disorders\u2014a review from students to students. J Neurochem 138:785\u2013805","journal-title":"J Neurochem"},{"key":"899_CR65","doi-asserted-by":"publisher","first-page":"78","DOI":"10.31083\/j.fbl2902078","volume":"29","author":"Y Li","year":"2024","unstructured":"Li Y, Li H, Liang W, Li Y, Wang Z (2024) The large ectodomain of APP prevents APP from being directly cleaved by \u03b3-secretase. Front Biosci 29:78","journal-title":"Front Biosci"},{"key":"899_CR66","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S1357-2725(03)00133-X","volume":"35","author":"Y Ling","year":"2003","unstructured":"Ling Y, Morgan K, Kalsheker N (2003) Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer\u2019s disease. Int J Biochem Cell Biol 35:1505\u20131535","journal-title":"Int J Biochem Cell Biol"},{"key":"899_CR67","doi-asserted-by":"crossref","unstructured":"Luo M, Zhou J, Sun C, Chen W, Fu C, Si C, Zhang Y, Geng Y, Chen Y (2025) APP \u03b2-CTF triggers cell-autonomous synaptic toxicity independent of A\u03b2. eLife 13:RP100968","DOI":"10.7554\/eLife.100968.3"},{"key":"899_CR68","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-1-4939-6688-2_10","volume":"1538","author":"E Luquet","year":"2017","unstructured":"Luquet E, Biesemann C, Munier A, Herzog E (2017) Purification of synaptosome populations using fluorescence-activated synaptosome sorting. Methods Mol Biol 1538:121\u2013134","journal-title":"Methods Mol Biol"},{"key":"899_CR69","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/jcb.30141","volume":"122","author":"P Madhu","year":"2021","unstructured":"Madhu P, Mukhopadhyay S (2021) Distinct types of amyloid-\u03b2 oligomers displaying diverse neurotoxicity mechanisms in Alzheimer\u2019s disease. J Cell Biochem 122:1594\u20131608","journal-title":"J Cell Biochem"},{"key":"899_CR70","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/978-3-7091-0932-8_25","volume":"970","author":"E Marcello","year":"2012","unstructured":"Marcello E, Epis R, Saraceno C, Di Luca M (2012) Synaptic dysfunction in Alzheimer\u2019s disease. Adv Exp Med Biol 970:573\u2013601","journal-title":"Adv Exp Med Biol"},{"key":"899_CR71","doi-asserted-by":"crossref","unstructured":"Martinsson I, Quintino L, Garcia MG, Konings SC, Torres-Garcia L, Svanbergsson A, Stange O, England R, Deierborg T, Li JY, Lundberg C (2022) A\u03b2\/amyloid precursor protein-induced hyperexcitability and dysregulation of homeostatic synaptic plasticity in neuron models of Alzheimer\u2019s disease. Front Aging Neurosci 14:946297","DOI":"10.3389\/fnagi.2022.946297"},{"key":"899_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58879-z","volume":"16","author":"RI McGeachan","year":"2025","unstructured":"McGeachan RI, Meftah S, Taylor LW, Catterson JH, Negro D, Bonthron C, Holt K, Tulloch J, Rose JL, Gobbo F et al (2025) Divergent actions of physiological and pathological amyloid-\u03b2 on synapses in live human brain slice cultures. Nat Commun 16:3753","journal-title":"Nat Commun"},{"key":"899_CR73","doi-asserted-by":"publisher","first-page":"13168","DOI":"10.3390\/ijms222313168","volume":"22","author":"NE Mckean","year":"2021","unstructured":"Mckean NE, Handley RR, Snell RG (2021) A review of the current mammalian models of Alzheimer\u2019s disease and challenges that need to be overcome. Int J Mol Sci 22:13168","journal-title":"Int J Mol Sci"},{"key":"899_CR74","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.pneurobio.2008.05.002","volume":"85","author":"T M\u00fcller","year":"2008","unstructured":"M\u00fcller T, Meyer HE, Egensperger R, Marcus K (2008) The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics\u2014relevance for Alzheimer\u2019s disease. Prog Neurobiol 85:393\u2013406","journal-title":"Prog Neurobiol"},{"key":"899_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-014-1347-2","volume":"129","author":"HS Nhan","year":"2015","unstructured":"Nhan HS, Chiang K, Koo EH (2015) The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes. Acta Neuropathol 129:1\u201319","journal-title":"Acta Neuropathol"},{"key":"899_CR76","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/362075a0","volume":"362","author":"I Nishimoto","year":"1993","unstructured":"Nishimoto I, Okamoto T, Matsuura Y, Takahashi S, Okamoto T, Murayama Y, Ogata E (1993) Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o). Nature 362:75\u201379","journal-title":"Nature"},{"key":"899_CR77","first-page":"1","volume":"83","author":"R Nitrini","year":"2025","unstructured":"Nitrini R, Studart-Neto A (2025) Monoclonal antibodies against beta-amyloid protein (lecanemab and donanemab) should not be used in the treatment of Alzheimer\u2019s disease. Arq Neuropsiquiatr 83:1\u20135","journal-title":"Arq Neuropsiquiatr"},{"key":"899_CR78","doi-asserted-by":"crossref","unstructured":"Noorda K, Noorda K, Sabbagh MN, Bertelson J, Singer J, Decourt B (2024) Amyloid-directed antibodies: past, present, and future. J Alzheimers Dis 101(s1):S3\u2013S22","DOI":"10.3233\/JAD-240189"},{"key":"899_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38595-2","volume":"14","author":"TH Ogunmowo","year":"2023","unstructured":"Ogunmowo TH, Jing H, Raychaudhuri S, Kusick GF, Imoto Y, Li S, Itoh K, Ma Y, Jafri H, Dalva MB et al (2023) Membrane compression by synaptic vesicle exocytosis triggers ultrafast endocytosis. Nat Commun 14:2888","journal-title":"Nat Commun"},{"key":"899_CR80","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-025-03565-2","volume":"31","author":"HS-H Oh","year":"2025","unstructured":"Oh HS-H, Urey DY, Karlsson L, Zhu Z, Shen Y, Farinas A, Timsina J, Duggan MR, Chen J, Guldner IH et al (2025) A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer\u2019s disease. Nat Med 31:1592\u20131603","journal-title":"Nat Med"},{"key":"899_CR81","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nn.2583","volume":"13","author":"J Palop","year":"2010","unstructured":"Palop J, Mucke L (2010) Amyloid-\u03b2\u2013induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks. Nat Neurosci 13:812\u2013818","journal-title":"Nat Neurosci"},{"key":"899_CR82","unstructured":"Pantelopulos GA (2022) Lipid Bilayer Phase Separations, Cholesterol, and Their Effect on the Amyloid Precursor Protein C99 (Doctoral dissertation, Boston University). https:\/\/hdl.handle.net\/2144\/44810"},{"key":"899_CR83","doi-asserted-by":"publisher","first-page":"e2212207119","DOI":"10.1073\/pnas.2212207119","volume":"119","author":"GA Pantelopulos","year":"2022","unstructured":"Pantelopulos GA, Matsuoka D, Hutchison JM, Sanders CR, Sugita Y, Straub JE, Thirumalai D (2022) Formation of extramembrane \u03b2-strands controls dimerization of transmembrane helices in amyloid precursor protein C99. Proc Natl Acad Sci USA 119:e2212207119","journal-title":"Proc Natl Acad Sci USA"},{"key":"899_CR84","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.bbamem.2018.04.002","volume":"1860","author":"GA Pantelopulos","year":"2018","unstructured":"Pantelopulos GA, Straub JE, Thirumalai D, Sugita Y (2018) Structure of APP-C991-99 and implications for role of extra-membrane domains in function and oligomerization. Biochim Biophys Acta Biomembr 1860:1698\u20131708","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"899_CR85","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/14712598.2025.2463963","volume":"25","author":"F Panza","year":"2025","unstructured":"Panza F, Dibello V, Sardone R, Zupo R, Castellana F, Leccisotti I, Moretti MC, Altamura M, Bellomo A, Daniele A et al (2025) Successes and failures: the latest advances in the clinical development of amyloid-\u03b2-targeting monoclonal antibodies for treating Alzheimer\u2019s disease. Expert Opin Biol Ther 25:275\u2013283","journal-title":"Expert Opin Biol Ther"},{"key":"899_CR86","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1016\/j.neuron.2025.04.010","volume":"113","author":"A Papanikolaou","year":"2025","unstructured":"Papanikolaou A, Graykowski D, Lee BI, Yang M, Ellingford R, Z\u00fcnkler J, Bond SA, Rowland JM, Rajani RM, Harris SS et al (2025) Selectively vulnerable deep cortical layer 5\/6 fast-spiking interneurons in Alzheimer\u2019s disease models in vivo. Neuron 113:2265\u20132279.e7","journal-title":"Neuron"},{"key":"899_CR87","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3233\/JAD-2010-101020","volume":"22","author":"MS Parihar","year":"2010","unstructured":"Parihar MS, Brewer GJ (2010) Amyloid-\u03b2 as a modulator of synaptic plasticity. J Alzheimers Dis 22:741\u2013763","journal-title":"J Alzheimers Dis"},{"key":"899_CR88","doi-asserted-by":"crossref","unstructured":"Pedersen KB, Ing\u00f3lfsson HI, Ramirez-Echemendia DP, Borges-Ara\u00fajo L, Andreasen MD, Empereur-Mot C, Melcr J, Ozturk TN, Bennett DWF, Kj\u00f8lbye LR et al (2024) The Martini 3 lipidome: expanded and refined parameters improve lipid phase behavior. ACS Central Sci 11:1598\u20131610","DOI":"10.1021\/acscentsci.5c00755"},{"key":"899_CR89","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1021\/ct9002114","volume":"5","author":"X Periole","year":"2009","unstructured":"Periole X, Cavalli M, Marrink S-J, Ceruso MA (2009) Combining an elastic network with a coarse-grained molecular force field: structure, dynamics, and intermolecular recognition. J Chem Theory Comput 5:2531\u20132543","journal-title":"J Chem Theory Comput"},{"key":"899_CR90","doi-asserted-by":"publisher","first-page":"101887","DOI":"10.1016\/j.isci.2020.101887","volume":"23","author":"F Perrin","year":"2020","unstructured":"Perrin F, Papadopoulos N, Suelves N, Opsomer R, Vadukul DM, Vrancx C, Smith SO, Vertommen D, Kienlen-Campard P, Constantinescu SN (2020) Dimeric transmembrane orientations of APP\/C99 regulate \u03b3-secretase processing line impacting signaling and oligomerization. iScience 23:101887","journal-title":"iScience"},{"key":"899_CR91","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1021\/acs.jctc.6b00986","volume":"13","author":"AB Poma","year":"2017","unstructured":"Poma AB, Cieplak M, Theodorakis PE (2017) Combining the MARTINI and structure-based coarse-grained approaches for the molecular dynamics studies of conformational transitions in proteins. J Chem Theory Comput 13:1366\u20131374","journal-title":"J Chem Theory Comput"},{"key":"899_CR92","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/alzrt30","volume":"2","author":"E Portelius","year":"2010","unstructured":"Portelius E, Dean RA, Gustavsson MK, Andreasson U, Zetterberg H, Siemers E, Blennow K (2010) A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer disease. Alzheimers Res Ther 2:7","journal-title":"Alzheimers Res Ther"},{"key":"899_CR93","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.pneurobio.2011.02.002","volume":"93","author":"DT Proctor","year":"2011","unstructured":"Proctor DT, Coulson EJ, Dodd PR (2011) Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer\u2019s disease. Prog Neurobiol 93:509\u2013521","journal-title":"Prog Neurobiol"},{"key":"899_CR94","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13778","volume":"22","author":"J Raj\u00e3o-Saraiva","year":"2023","unstructured":"Raj\u00e3o-Saraiva J, Dunot J, Ribera A, Temido-Ferreira M, Coelho JE, K\u00f6nig S, Moreno S, Enguita FJ, Willem M, Kins S et al (2023) Age-dependent NMDA receptor function is regulated by the amyloid precursor protein. Aging Cell 22:e13778","journal-title":"Aging Cell"},{"key":"899_CR95","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuropharm.2010.02.011","volume":"59","author":"AD Randall","year":"2010","unstructured":"Randall AD, Witton J, Booth C, Hynes-Allen A, Brown JT (2010) The functional neurophysiology of the amyloid precursor protein (APP) processing pathway. Neuropharmacology 59:243\u2013267","journal-title":"Neuropharmacology"},{"key":"899_CR96","doi-asserted-by":"publisher","first-page":"110629","DOI":"10.1016\/j.isci.2024.110629","volume":"27","author":"A Ray","year":"2024","unstructured":"Ray A, Loghinov I, Ravindranath V, Barth AL (2024) Early hippocampal hyperexcitability and synaptic reorganization in mouse models of amyloidosis. iScience 27:110629","journal-title":"iScience"},{"key":"899_CR97","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1038\/sj.emboj.7600860","volume":"24","author":"C Reinhard","year":"2005","unstructured":"Reinhard C, H\u00e9bert SS, De Strooper B (2005) The amyloid-beta precursor protein: integrating structure with biological function. EMBO J 24:3996\u20134006","journal-title":"EMBO J"},{"key":"899_CR98","doi-asserted-by":"publisher","first-page":"12083","DOI":"10.1523\/JNEUROSCI.2513-11.2011","volume":"31","author":"S Restituito","year":"2011","unstructured":"Restituito S, Khatri L, Ninan I, Mathews PM, Liu X, Weinberg RJ, Ziff EB (2011) Synaptic autoregulation by metalloproteases and \u03b3-secretase. J Neurosci 31:12083\u201312093","journal-title":"J Neurosci"},{"key":"899_CR99","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.exger.2004.06.020","volume":"39","author":"MJ Rowan","year":"2004","unstructured":"Rowan MJ, Klyubin I, Wang Q, Anwyl R (2004) Mechanisms of the inhibitory effects of amyloid beta-protein on synaptic plasticity. Exp Gerontol 39:1661\u20131667","journal-title":"Exp Gerontol"},{"key":"899_CR100","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3233\/JAD-220983","volume":"92","author":"N Samudra","year":"2023","unstructured":"Samudra N, Ranasinghe K, Kirsch H, Rankin K, Miller B (2023) Etiology and clinical significance of network hyperexcitability in Alzheimer\u2019s disease: unanswered questions and next steps. J Alzheimers Dis 92:13\u201327","journal-title":"J Alzheimers Dis"},{"key":"899_CR101","doi-asserted-by":"crossref","unstructured":"Sang Z (2025) Lecanemab (Leqembi): an amyloid beta monoclonal antibody approved for the treatment of Alzheimer\u2019s disease. In Drug Discovery Stories. Elsevier, pp 647\u2013652.","DOI":"10.1016\/B978-0-443-23932-8.00035-2"},{"key":"899_CR102","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.neuron.2016.09.058","volume":"92","author":"CT Schanzenb\u00e4cher","year":"2016","unstructured":"Schanzenb\u00e4cher CT, Sambandan S, Langer JD, Schuman EM (2016) Nascent proteome remodeling following homeostatic scaling at hippocampal synapses. Neuron 92:358\u2013371","journal-title":"Neuron"},{"key":"899_CR103","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/j.1471-4159.2010.07044.x","volume":"115","author":"G Schettini","year":"2010","unstructured":"Schettini G, Govoni S, Racchi M, Rodriguez G (2010) Phosphorylation of APP-CTF-AICD domains and interaction with adaptor proteins: signal transduction and\/or transcriptional role\u2014relevance for Alzheimer pathology: APP-CTF-AICD phosphorylation. J Neurochem 115:1299\u20131308","journal-title":"J Neurochem"},{"key":"899_CR104","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s40478-023-01577-y","volume":"11","author":"S Schilling","year":"2023","unstructured":"Schilling S, Pradhan A, Heesch A, Helbig A, Blennow K, Koch C, Bertgen L, Koo EH, Brinkmalm G, Zetterberg H et al (2023) Differential effects of familial Alzheimer\u2019s disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity. Acta Neuropathol Commun 11:87","journal-title":"Acta Neuropathol Commun"},{"key":"899_CR105","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3390\/biomedicines12051096","volume":"12","author":"TG Schreiner","year":"2024","unstructured":"Schreiner TG, Croitoru CG, Hodorog DN, Cuciureanu DI (2024) Passive anti-amyloid beta immunotherapies in Alzheimer\u2019s disease: from mechanisms to therapeutic impact. Biomedicines 12:1096","journal-title":"Biomedicines"},{"key":"899_CR106","doi-asserted-by":"publisher","first-page":"10043","DOI":"10.1021\/acs.jpcb.4c04140","volume":"128","author":"F Schuhmann","year":"2024","unstructured":"Schuhmann F, Bordallo HN, Pezeshkian W (2024) Physics-based protein networks might recover effectful mutations\u2500a case study on cathepsin G. J Phys Chem B 128:10043\u201310050","journal-title":"J Phys Chem B"},{"key":"899_CR107","doi-asserted-by":"publisher","first-page":"9136","DOI":"10.1021\/acs.jctc.5c00833","volume":"21","author":"F Schuhmann","year":"2025","unstructured":"Schuhmann F, Stevens JA, Rahmani N, Lindahl I, Brown CM, Brasnett C, Anastasiou D, Vidal AB, Geiger B, Marrink SJ et al (2025) TS2CG as a membrane builder. J Chem Theory Comput 21:9136\u20139146","journal-title":"J Chem Theory Comput"},{"key":"899_CR108","doi-asserted-by":"publisher","first-page":"5991","DOI":"10.3390\/ijms22115991","volume":"22","author":"M Sciaccaluga","year":"2021","unstructured":"Sciaccaluga M, Megaro A, Bellomo G, Ruffolo G, Romoli M, Palma E, Costa C (2021) An unbalanced synaptic transmission: cause or consequence of the amyloid oligomers neurotoxicity? Int J Mol Sci 22:5991","journal-title":"Int J Mol Sci"},{"key":"899_CR109","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.3390\/ijms232112924","volume":"23","author":"U Sehar","year":"2022","unstructured":"Sehar U, Rawat P, Reddy AP, Kopel J, Reddy PH (2022) Amyloid beta in aging and Alzheimer\u2019s disease. Int J Mol Sci 23:12924","journal-title":"Int J Mol Sci"},{"key":"899_CR110","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1046\/j.1471-4159.2002.00901.x","volume":"81","author":"N Sergeant","year":"2002","unstructured":"Sergeant N, David J-P, Champain D, Ghestem A, Wattez A, Delacourte A (2002) Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer\u2019s disease: loss of APP-CTFs linked to tau pathology in AD. J Neurochem 81:663\u2013672","journal-title":"J Neurochem"},{"key":"899_CR111","doi-asserted-by":"publisher","first-page":"e193407","DOI":"10.1172\/JCI193407","volume":"135","author":"A Siddu","year":"2025","unstructured":"Siddu A, Natale S, Wong CH, Shaye H, S\u00fcdhof TC (2025) Aggregation shifts amyloid-\u03b2 peptides from synaptogenic to synaptotoxic. J Clin Invest 135:e193407","journal-title":"J Clin Invest"},{"key":"899_CR112","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1523\/JNEUROSCI.16-03-00899.1996","volume":"16","author":"M Simons","year":"1996","unstructured":"Simons M, De SB, Multhaup G, Tienari PJ, Dotti CG, Beyreuther K (1996) Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons. J Neurosci 16:899\u2013908","journal-title":"J Neurosci"},{"key":"899_CR113","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41592-021-01098-3","volume":"18","author":"PCT Souza","year":"2021","unstructured":"Souza PCT, Alessandri R, Barnoud J, Thallmair S, Faustino I, Gr\u00fcnewald F, Patmanidis I, Abdizadeh H, Bruininks BMH, Wassenaar TA et al (2021) Martini 3: a general purpose force field for coarse-grained molecular dynamics. Nat Methods 18:382\u2013388","journal-title":"Nat Methods"},{"key":"899_CR114","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2174\/156720506776383068","volume":"3","author":"J Standridge","year":"2006","unstructured":"Standridge J (2006) Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer\u2019s disease. Curr Alzheimer Res 3:95\u2013108","journal-title":"Curr Alzheimer Res"},{"key":"899_CR115","first-page":"1","volume":"177","author":"LM Tai","year":"2021","unstructured":"Tai LM, Maldonado Weng J, LaDu MJ, Brady ST (2021) Relevance of transgenic mouse models for Alzheimer\u2019s disease. Prog Mol Biol Transl Sci 177:1\u201348","journal-title":"Prog Mol Biol Transl Sci"},{"key":"899_CR116","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1523\/JNEUROSCI.5167-03.2004","volume":"24","author":"RH Takahashi","year":"2004","unstructured":"Takahashi RH, Almeida CG, Kearney PF, Yu F, Lin MT, Milner TA, Gouras GK (2004) Oligomerization of Alzheimer\u2019s beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 24:3592\u20133599","journal-title":"J Neurosci"},{"key":"899_CR117","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/emmm.201100195","volume":"4","author":"R Tamayev","year":"2012","unstructured":"Tamayev R, Matsuda S, Arancio O, D\u2019Adamio L (2012) \u03b2-but not \u03b3-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia: sAPP\u03b2\/\u03b2-CTF and not A\u03b2 cause memory deficits. EMBO Mol Med 4:171\u2013179","journal-title":"EMBO Mol Med"},{"key":"899_CR118","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1750-1326-4-28","volume":"4","author":"R Tamayev","year":"2009","unstructured":"Tamayev R, Zhou D, D\u2019Adamio L (2009) The interactome of the amyloid beta precursor protein family members is shaped by phosphorylation of their intracellular domains. Mol Neurodegener 4:28","journal-title":"Mol Neurodegener"},{"key":"899_CR119","doi-asserted-by":"publisher","first-page":"e52612","DOI":"10.7554\/eLife.52612","volume":"9","author":"MD Tambini","year":"2020","unstructured":"Tambini MD, Norris KA, D\u2019Adamio L (2020) Opposite changes in APP processing and human A\u03b2 levels in rats carrying either a protective or a pathogenic APP mutation. Elife 9:e52612","journal-title":"Elife"},{"key":"899_CR120","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13195-017-0234-1","volume":"9","author":"S Thordardottir","year":"2017","unstructured":"Thordardottir S, Kinhult St\u00e5hlbom A, Almkvist O, Thonberg H, Eriksdotter M, Zetterberg H, Blennow K, Graff C (2017) The effects of different familial Alzheimer\u2019s disease mutations on APP processing in vivo. Alzheimers Res Ther 9:9","journal-title":"Alzheimers Res Ther"},{"key":"899_CR121","doi-asserted-by":"publisher","first-page":"694","DOI":"10.4161\/auto.27802","volume":"10","author":"Y Tian","year":"2014","unstructured":"Tian Y, Chang JC, Greengard P, Flajolet M (2014) The convergence of endosomal and autophagosomal pathways: implications for APP-CTF degradation: implications for APP-CTF degradation. Autophagy 10:694\u2013696","journal-title":"Autophagy"},{"key":"899_CR122","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1073\/pnas.94.8.4125","volume":"94","author":"PJ Tienari","year":"1997","unstructured":"Tienari PJ, Ida N, Ikonen E, Simons M, Weidemann A, Multhaup G, Masters CL, Dotti CG, Beyreuther K (1997) Intracellular and secreted Alzheimer beta-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons. Proc Natl Acad Sci USA 94:4125\u20134130","journal-title":"Proc Natl Acad Sci USA"},{"key":"899_CR123","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3233\/JAD-210397","volume":"88","author":"S Tok","year":"2022","unstructured":"Tok S, Ahnaou A, Drinkenburg W (2022) Functional neurophysiological biomarkers of early-stage Alzheimer\u2019s disease: a perspective of network hyperexcitability in disease progression. J Alzheimers Dis 88:809\u2013836","journal-title":"J Alzheimers Dis"},{"key":"899_CR124","doi-asserted-by":"publisher","first-page":"e1004568","DOI":"10.1371\/journal.pmed.1004568","volume":"22","author":"R Tonegawa-Kuji","year":"2025","unstructured":"Tonegawa-Kuji R, Hou Y, Hu B, Lorincz-Comi N, Pieper AA, Tousi B, Leverenz JB, Cheng F (2025) Efficacy and safety of passive immunotherapies targeting amyloid beta in Alzheimer\u2019s disease: a systematic review and meta-analysis. PLoS Med 22:e1004568","journal-title":"PLoS Med"},{"key":"899_CR125","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mcn.2012.07.009","volume":"51","author":"S-H Tyan","year":"2012","unstructured":"Tyan S-H, Shih AY-J, Walsh JJ, Maruyama H, Sarsoza F, Ku L, Eggert S, Hof PR, Koo EH, Dickstein DL (2012) Amyloid precursor protein (APP) regulates synaptic structure and function. Mol Cell Neurosci 51:43\u201352","journal-title":"Mol Cell Neurosci"},{"key":"899_CR126","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-020-02234-7","volume":"141","author":"L Vaillant-Beuchot","year":"2021","unstructured":"Vaillant-Beuchot L, Mary A, Pardossi-Piquard R, Bourgeois A, Lauritzen I, Eysert F, Kinoshita PF, Cazareth J, Badot C, Fragaki K et al (2021) Accumulation of amyloid precursor protein C-terminal fragments triggers mitochondrial structure, function, and mitophagy defects in Alzheimer\u2019s disease models and human brains. Acta Neuropathol 141:39\u201365","journal-title":"Acta Neuropathol"},{"key":"899_CR127","doi-asserted-by":"publisher","first-page":"5411","DOI":"10.1016\/j.cell.2023.09.028","volume":"186","author":"M van Oostrum","year":"2023","unstructured":"van Oostrum M, Blok TM, Giandomenico SL, Tom Dieck S, Tushev G, F\u00fcrst N, Langer JD, Schuman EM (2023) The proteomic landscape of synaptic diversity across brain regions and cell types. Cell 186:5411\u20135427.e23","journal-title":"Cell"},{"key":"899_CR4","doi-asserted-by":"publisher","unstructured":"Vargas Baron SK (2024) Regulation of amyloid precursor protein processing pathway by \u03b2-secretase and its impact on Alzheimer\u2019s disease physiopathology. Agricultural sciences. Universit\u00e9 Grenoble Alpes. https:\/\/doi.org\/10.70675\/652f012dz5154z4a59z9326zdc0fca7e4638","DOI":"10.70675\/652f012dz5154z4a59z9326zdc0fca7e4638"},{"key":"899_CR128","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1385\/JMN:17:2:157","volume":"17","author":"R Vassar","year":"2001","unstructured":"Vassar R (2001) The beta-secretase, BACE: a prime drug target for Alzheimer\u2019s disease. J Mol Neurosci 17:157\u2013170","journal-title":"J Mol Neurosci"},{"key":"899_CR129","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00401-015-1386-3","volume":"129","author":"KL Viola","year":"2015","unstructured":"Viola KL, Klein WL (2015) Amyloid \u03b2 oligomers in Alzheimer\u2019s disease pathogenesis, treatment, and diagnosis. Acta Neuropathol 129:183\u2013206","journal-title":"Acta Neuropathol"},{"key":"899_CR130","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","volume":"101","author":"DM Walsh","year":"2007","unstructured":"Walsh DM, Selkoe DJ (2007) A beta oligomers - a decade of discovery. J Neurochem 101:1172\u20131184","journal-title":"J Neurochem"},{"key":"899_CR131","doi-asserted-by":"publisher","first-page":"8677","DOI":"10.1523\/JNEUROSCI.2440-08.2008","volume":"28","author":"H Wang","year":"2008","unstructured":"Wang H, Song L, Laird F, Wong P, Lee H-K (2008) BACE1 knock-outs display deficits in activity-dependent potentiation of synaptic transmission at mossy fiber to CA3 synapses in the hippocampus. J Neurosci 28:8677\u20138681","journal-title":"J Neurosci"},{"key":"899_CR132","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2174\/156720512799361691","volume":"9","author":"Z Wang","year":"2012","unstructured":"Wang Z, Yang L, Zheng H (2012) Role of APP and A\u03b2 in synaptic physiology. Curr Alzheimer Res 9:217\u2013226","journal-title":"Curr Alzheimer Res"},{"key":"899_CR133","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nn.2476","volume":"13","author":"W Wei","year":"2010","unstructured":"Wei W, Nguyen LN, Kessels HW, Hagiwara H, Sisodia S, Malinow R (2010) Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nat Neurosci 13:190\u2013196","journal-title":"Nat Neurosci"},{"key":"899_CR134","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1042\/bj0900293","volume":"90","author":"VP Whittaker","year":"1964","unstructured":"Whittaker VP, Michaelson IA, Kirkland RJ (1964) The separation of synaptic vesicles from nerve-ending particles (\u2018synaptosomes\u2019). Biochem J 90:293\u2013303","journal-title":"Biochem J"},{"key":"899_CR135","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/00005072-199908000-00001","volume":"58","author":"CA Wilson","year":"1999","unstructured":"Wilson CA, Doms RW, VM Lee (1999) Intracellular APP processing and A\u03b2 production in Alzheimer disease. J Neuropathol Exp Neurol 58:787\u2013794","journal-title":"J Neuropathol Exp Neurol"},{"key":"899_CR136","doi-asserted-by":"publisher","first-page":"115410","DOI":"10.1016\/j.celrep.2025.115410","volume":"44","author":"P Wilson","year":"2025","unstructured":"Wilson P, Kim N, Cotter R, Parkes M, Cmelak L, Reed MN, Gramlich MW (2025) Presynaptic recycling pool density regulates spontaneous synaptic vesicle exocytosis rate and is upregulated in the presence of \u03b2-amyloid. Cell Rep 44:115410","journal-title":"Cell Rep"},{"key":"899_CR137","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.neubiorev.2016.03.025","volume":"65","author":"R Yan","year":"2016","unstructured":"Yan R, Fan Q, Zhou J, Vassar R (2016) Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer\u2019s disease. Neurosci Biobehav Rev 65:326\u2013340","journal-title":"Neurosci Biobehav Rev"},{"key":"899_CR138","doi-asserted-by":"publisher","first-page":"34019","DOI":"10.1074\/jbc.M105583200","volume":"276","author":"R Yan","year":"2001","unstructured":"Yan R, Munzner JB, Shuck ME, Bienkowski MJ (2001) BACE2 functions as an alternative alpha-secretase in cells. J Biol Chem 276:34019\u201334027","journal-title":"J Biol Chem"},{"key":"899_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110268","volume":"38","author":"D Zarhin","year":"2022","unstructured":"Zarhin D, Atsmon R, Ruggiero A, Baeloha H, Shoob S, Scharf O, Heim LR, Buchbinder N, Shinikamin O, Shapira I et al (2022) Disrupted neural correlates of anesthesia and sleep reveal early circuit dysfunctions in Alzheimer models. Cell Rep 38:110268","journal-title":"Cell Rep"},{"key":"899_CR140","doi-asserted-by":"publisher","first-page":"eabn9380","DOI":"10.1126\/scitranslmed.abn9380","volume":"14","author":"B Zhou","year":"2022","unstructured":"Zhou B, Lu JG, Siddu A, Wernig M, S\u00fcdhof TC (2022) Synaptogenic effect of APP-Swedish mutation in familial Alzheimer\u2019s disease. Sci Transl Med 14:eabn9380","journal-title":"Sci Transl Med"},{"key":"899_CR141","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13024-017-0159-y","volume":"12","author":"KM Zoltowska","year":"2017","unstructured":"Zoltowska KM, Maesako M, Lushnikova I, Takeda S, Keller LJ, Skibo G, Hyman BT, Berezovska O (2017) Dynamic presenilin 1 and synaptotagmin 1 interaction modulates exocytosis and amyloid \u03b2 production. Mol Neurodegener 12:15","journal-title":"Mol Neurodegener"},{"key":"899_CR142","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1126\/science.aay0198","volume":"365","author":"B Zott","year":"2019","unstructured":"Zott B, Simon MM, Hong W, Unger F, Chen-Engerer H-J, Frosch MP, Sakmann B, Walsh DM, Konnerth A (2019) A vicious cycle of \u03b2 amyloid-dependent neuronal hyperactivation. Science 365:559\u2013565","journal-title":"Science"}],"container-title":["The EMBO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44318-026-00899-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44318-026-00899-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44318-026-00899-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:34:35Z","timestamp":1790836475000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44318-026-00899-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":143,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10,1]]}},"alternative-id":["899"],"URL":"https:\/\/doi.org\/10.1038\/s44318-026-00899-6","relation":{},"ISSN":["1460-2075"],"issn-type":[{"value":"1460-2075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. BDCB reports honoraria from F. Hoffmann-La Roche and serves as the Vice Chair of the Atypical Alzheimer\u2019s Disease Professional Interest Area, organized by Alzheimer\u2019s Association International Society to Advance Alzheimer\u2019s Research and Treatment (ISTAART).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}